Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 1.00 |
| ▸ | CNR1 | P21554 | 12/20 | 1.00 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.94 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.94 |
| ▸ | FAAH | O00519 | 2/20 | 0.94 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.94 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.94 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.94 |
| ▸ | LDHA | P00338 | 1/20 | 0.94 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.94 |
| ▸ | GPR183 | P32249 | 1/20 | 0.94 |
| ▸ | DRD3 | P35462 | 1/20 | 0.94 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.94 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.94 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.88 |
| ▸ | HTR1A | P08908 | 1/20 | 0.88 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.88 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.88 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.88 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31545608 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL18909070 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL22705480 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL29422046 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL25098270 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL13214127 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL24351964 | 1.00 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| Dronabinol SCHEMBL3686519 | 0.97 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| Dronabinol SCHEMBL13394311 | 0.97 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| Dronabinol SCHEMBL24702729 | 0.97 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727539-A1 | A PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION | Pico IP, LLC (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4161580-B1 | CANNABINOID-HYALURONIC ACID BIOCONJUGATES | LONDON PHARMACEUTICALS AND RES CORPORATION (CA) | 2026-03-18 | — | — | EP | claimed |
| US-20250360176-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | LONDON PHARMACEUTICALS AND RES CORPORATION (CA) | 2025-11-27 | — | — | US | claimed |
| WO-2025213224-A1 | TREATMENT OF KCNT1-RELATED DISORDERS | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2025-10-16 | — | — | WO | claimed |
| US-20250268924-A1 | PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION | TERRY MILES J (US) | 2025-08-28 | — | — | US | claimed |
| US-20250109087-A1 | FULL SPECTRUM HEMP OIL COMPOSITIONS | CHEMTOR L P (US) | 2025-04-03 | — | — | US | claimed |
| EP-3518979-B1 | DILUTABLE FORMULATIONS OF CANNABINOIDS AND PROCESSES FOR THEIR PREPARATION | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2025-03-12 | — | — | EP | claimed |
| US-12201588-B2 | Full spectrum hemp oil compositions | Chemtor L.P. (US) | 2025-01-21 | — | — | US | claimed |
| US-20250019345-A1 | NEW CANNABINOID-GABAPENTINOID CONJUGATES AND USES THEREOF | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2025-01-16 | — | — | US | claimed |
| US-12198788-B2 | System for detecting an intraoral disease and determining a personalized treatment scheme and method of doing same | CANNIBITE BVBA (BE) | 2025-01-14 | — | — | US | claimed |
| EP-4164613-A1 | COMPOSITIONS FOR SOLUBILIZING WATER-INSOLUBLE ACTIVE INGREDIENTS | Chavan, Neha (US) | 2023-04-19 | — | — | EP | claimed |
| EP-4161580-A1 | CANNABINOID-HYALURONIC ACID BIOCONJUGATES | London Pharmaceuticals and Research Corporation (CA) | 2023-04-12 | — | — | EP | claimed |
| US-20230097799-A1 | FULL SPECTRUM HEMP OIL COMPOSITIONS | Chemtor L.P. | 2023-03-30 | — | — | US | claimed |
| US-20230023342-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2023-01-26 | — | — | US | claimed |
| WO-2022266767-A1 | CANNABINOID-CONTAINING FORMULA FOR SKIN CARE | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2022-12-29 | — | — | WO | claimed |
| US-11464827-B2 | Antiviral pharmaceutical compositions and method of manufacturing | ANEWSHA HOLDING GROUP LLC (US) | 2022-10-11 | — | — | US | claimed |
| US-20220234023-A1 | CHROMATOGRAPHIC MEDIA AND METHODS OF MAKING AND USING SAME | PROPRIETARY TECHNOLOGY ASSETS, LLC (US) | 2022-07-28 | — | — | US | claimed |
| US-20220202712-A1 | SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-06-30 | — | — | US | claimed |
| US-20220110911-A1 | CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE | VIALPANDO, LLC (US) | 2022-04-14 | — | — | US | claimed |
| CN-113966213-A | Self-emulsifying drug delivery system for delivery of lipophilic compounds | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202712-A1 | SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS | LIPA, LIPC, LSS | CNR2 970/4885CNR1 670/4885ABHD12 138/4885 |
| US-20230023342-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | CNR2, CNR1, GPR18 | CNR2 1/4885CNR1 2/4885ABHD12 2113/4885 |
| US-20250019345-A1 | NEW CANNABINOID-GABAPENTINOID CONJUGATES AND USES THEREOF | CNR2, CNR1, GABRA4 | CNR2 1/4885CNR1 2/4885ABHD12 2085/4885 |
| US-20250360176-A1 | CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS | CNR2, CNR1, TAS2R60 | CNR2 1/4885CNR1 2/4885ABHD12 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.